Diagnosis and acute management of migraine

Author/s: 
Tzankova, V., Becker, W. J., Chan, T. L. H.
Date Added: 
February 8, 2023
Journal/Publication: 
CMAJ
Publisher: 
CMA Impact Inc
Publication Date: 
January 30, 2023
Issue: 
4
Volume: 
195
Pages: 
E153-E158
Type: 
Meta-analyses, Reviews, and Guidelines
Format: 
Article
DOI (1): 
10.1503/cmaj.211969
PMID (1): 
36717129

RPR Commentary

A concise review of the presumed cause and treatment of migraine headaches. James W. Mold, MD, MPH

Abstract

Migraine is a leading cause of disability across all age groups.
• Routine imaging is not recommended in patients with migraine
who have no red flags, atypical symptoms or abnormal findings
on neurologic examination.
• A stratified approach for acute migraine treatment empowers
patients to choose from different treatment options
depending on attack symptoms and severity and encourages
patients to combine medications from different classes.
• Effective acute migraine treatment includes acetaminophen,
nonsteroidal anti-inflammatory drugs and triptans.
• Ubrogepant and rimegepant are new, effective migraine
treatments, suitable for patients with cardiovascular disease in
whom triptans are contraindicated.

Text Availability

Free full text